236 All Oral Fixed-Dose Combination Sofosbuvir/Ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-Experienced Genotype 1 HCVInfected Patients: The Phase 3 Ion-2 Study
Kwo, Paul Y., Reddy, K. Rajender, Pockros, Paul J., Di Bisceglie, Adrian M., Arora, Sanjeev, Yang, Jenny C., Dvory-Sobol, Hadas, Zhu, Yanni, Pang, Phil, Symonds, William T., McHutchison, John G., SulkVolume:
146
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(14)63287-X
Date:
May, 2014
File:
PDF, 361 KB
english, 2014